Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach

References

• Abd El-Alim SH, Kassem AA, Basha M, et al. (2019). Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation. Int J Pharm 563:293–303.
   PubMed Web of Science ®Google Scholar
• Abd Elwakil MM, Mabrouk MT, Helmy MW, et al. (2018). Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma. Nanomedicine (Lond) 13:2015–35.
   PubMed Web of Science ®Google Scholar
• Abdelmoneem MA, Elnaggar MA, Hammady RS, et al. (2019). Dual-targeted lactoferrin shell-oily core nanocapsules for synergistic targeted/herbal therapy of hepatocellular carcinoma. ACS Appl Mater Interfaces 11:26731–44.
   PubMed Web of Science ®Google Scholar
• Abdelmoneem MA, Mahmoud M, Zaky A, et al. (2018). Decorating protein nanospheres with lactoferrin enhances oral COX-2 inhibitor/herbal therapy of hepatocellular carcinoma. Nanomedicine (Lond) 13:2377–95.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Singhal M, Amin S, et al. (2017). Bile salt stabilized vesicles (bilosomes): a novel nano-pharmaceutical design for oral delivery of proteins and peptides. Curr Pharm Des 23:1575–88.
   PubMed Web of Science ®Google Scholar
• Ahmed S, Kassem MA, Sayed S. (2020). Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int J Nanomed 15:9783–98.
   PubMed Web of Science ®Google Scholar
• Al-Shahari EA, El Barky AR, Mohamed TM, et al. (2021). Doxorubicin, L-arginine, or their combination as a prophylactic agent against hepatic carcinoma in mice. Environ Sci Pollut Res Int 28:37661–71.
   PubMed Web of Science ®Google Scholar
• Alshaymaa A, et al. (2012). Regression of Murine Ehrlich ascites carcinoma using tumor-targeting salmonella VNP20009-comparison with the effect of the anticancer drug doxorubicin. Adv Cancer 8:1103–11.
   Google Scholar
• Anwekar H, Patel S, Singhai A. (2011). Liposome-as drug carriers. Int J Pharm Life Sci 2:945–51.
   Google Scholar
• Arya G, Das M, Sahoo SK. (2018). Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed Pharmacother 102:555–66.
   PubMed Web of Science ®Google Scholar
• Ashfaq M, Shah S, Rasul A, et al. (2022). Enhancement of the solubility and bioavailability of pitavastatin through a self-nanoemulsifying drug delivery system (SNEDDS). Pharmaceutics 14:482.
   PubMed Web of Science ®Google Scholar
• Azhar Shekoufeh Bahari L, Hamishehkar H. (2016). The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review. Adv Pharm Bull 6:143–51.
   PubMedGoogle Scholar
• Bytautaite M, Petrikaite V. (2020). Comparative study of lipophilic statin activity in 2D and 3D in vitro models of human breast cancer cell lines MDA-MB-231 and MCF-7. Onco Targets Ther 13:13201–9.
   PubMed Web of Science ®Google Scholar
• Cárdenas PA, Kratz JM, Hernández A, et al. (2017). In vitro intestinal permeability studies, pharmacokinetics and tissue distribution of 6-methylcoumarin after oral and intraperitoneal administration in Wistar rats. Braz J Pharm Sci 53:1–9.
   Web of Science ®Google Scholar
• Chen Y-H, Chen Y-C, Lin C-C, et al. (2020). Synergistic anticancer effects of gemcitabine with pitavastatin on pancreatic cancer cell line MIA PaCa-2 in vitro and in vivo. Cancer Manag Res 12:4645–65.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lu Y, Chen J, et al. (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm 376:153–60.
   PubMed Web of Science ®Google Scholar
• Danaei M, Dehghankhold M, Ataei S, et al. (2018). Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10:57.
   PubMed Web of Science ®Google Scholar
• De Wolf E, Wolf CD, Richardson A. (2018). ABT‑737 and pictilisib synergistically enhance pitavastatin‑induced apoptosis in ovarian cancer cells. Oncol Lett 15:1979–84.
   PubMed Web of Science ®Google Scholar
• Elmoslemany RM, Abdallah OY, El-Khordagui LK, et al. (2012). Propylene glycol liposomes as a topical delivery system for miconazole nitrate: comparison with conventional liposomes. AAPS PharmSciTech 13:723–31.
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Shamma RN, Farouk F, et al. (2020). Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J Liposome Res 30:1–11.
   PubMed Web of Science ®Google Scholar
• El-Wahab A, Samia M, Fouda FM. (2009). Histological and histochemical study on the effect of Ehrlich ascites carcinoma on the liver and kidney of mice and the possible protective role of tetrodotoxin. Egypt J Biol 11:13–25.
   Google Scholar
• Elzoghby AO, Abdelmoneem MA, Hassanin IA, et al. (2020). Lactoferrin, a multi-functional glycoprotein: active therapeutic, drug nanocarrier & targeting ligand. Biomaterials 263:120355.
   PubMed Web of Science ®Google Scholar
• He H, Lu Y, Qi J, et al. (2019). Adapting liposomes for oral drug delivery. Acta Pharm Sin B 9:36–48.
   PubMed Web of Science ®Google Scholar
• Hegazy RR, Mansour DF, Salama AA, et al. (2019). Regulation of PKB/Akt-pathway in the chemopreventive effect of lactoferrin against diethylnitrosamine-induced hepatocarcinogenesis in rats. Pharmacol Rep 71:879–91.
   PubMed Web of Science ®Google Scholar
• Hernandez-Meza G, Vietti Violi N, Said D, et al. (2021). MRI is the most commonly used imaging modality for HCC screening at a tertiary care transplant center. Abdom Radiol (NY) 46:5142–51.
   PubMed Web of Science ®Google Scholar
• Hu T, Shen H, Huang H, et al. (2020). Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling. Anticancer Drugs 31:377–84.
   PubMed Web of Science ®Google Scholar
• Imam SS, Alshehri S, Altamimi MA, et al. (2022). Formulation of chitosan-coated apigenin bilosomes: in vitro characterization, antimicrobial and cytotoxicity assessment. Polymers (Basel) 14:921.
   PubMed Web of Science ®Google Scholar
• Ishida J, Konishi M, Ebner N, et al. (2016). Repurposing of approved cardiovascular drugs. J Transl Med 14:1–15.
   PubMed Web of Science ®Google Scholar
• Jiang R, Du X, Lönnerdal B. (2014). Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. J Pediatr Gastroenterol Nutr 59:642–52.
   PubMed Web of Science ®Google Scholar
• Kaasalainen M, Aseyev V, von Haartman E, et al. (2017). Size, stability, and porosity of mesoporous nanoparticles characterized with light scattering. Nanoscale Res Lett 12:1–10.
   PubMed Web of Science ®Google Scholar
• Kanwar JR, Samarasinghe RM, Sehgal R, et al. (2012). Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases. JCST 04:31–42.
   Google Scholar
• Kapoor R, Gundpatil DB, Somani BL, et al. (2014). Anticancer effect of dl-glyceraldehyde and 2-deoxyglucose in ehrlich ascites carcinoma bearing mice and their effect on liver, kidney and haematological parameters. Indian J Clin Biochem 29:213–20.
   PubMedGoogle Scholar
• Kawaguchi K, Sakai Y, Terashima T, et al. (2021). Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease. Medicine 100:e26835.
   PubMed Web of Science ®Google Scholar
• Kawano K, Onose E, Hattori Y, et al. (2009). Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharm 6:98–104.
   PubMed Web of Science ®Google Scholar
• Kiartivich S, Wei Y, Liu J, et al. (2017). Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells. Oncol Lett 13:2799–804.
   PubMed Web of Science ®Google Scholar
• Kijanska M, J, Kelm In vitro 3D spheroids and microtissues: ATP-based cell viability and toxicity assays, in Assay Guidance Manual, S. Markossian, et al. Editors. 2004, Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences.
   Google Scholar
• Kumar NS, Nisha N, Nirmal J, et al. (2011). HPLC determination of pitavastatin calcium in pharmaceutical dosage forms. Pharm Anal Acta 2:1–4.
   Google Scholar
• Lee EH, Kim A, Oh Y-K, et al. (2005). Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26:205–10.
   PubMed Web of Science ®Google Scholar
• Li M, Du C, Guo N, et al. (2019). Composition design and medical application of liposomes. Eur J Med Chem 164:640–53.
   PubMed Web of Science ®Google Scholar
• Li P, Hao J, Li H, et al. (2018). Development of an enteric nanoparticle of marine sulfated polysaccharide propylene glycol alginate sodium sulfate for oral administration: formulation design, pharmacokinetics and efficacy. J Pharm Pharmacol 70:740–8.
   PubMed Web of Science ®Google Scholar
• Limdi J, Hyde G. (2003). Evaluation of abnormal liver function tests. Postgrad Med J 79:307–12.
   PubMed Web of Science ®Google Scholar
• Liu Y, Bravo KMC, Liu J. (2021). Targeted liposomal drug delivery: a nanoscience and biophysical perspective. Nanoscale Horiz 6:78–94.
   PubMed Web of Science ®Google Scholar
• Liu J, Kuznetsova LA, Edwards GO, et al. (2007). Functional three-dimensional HepG2 aggregate cultures generated from an ultrasound trap: comparison with HepG2 spheroids. J Cell Biochem 102:1180–9.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu X, Liang J, et al. (2021). Immunotherapy for hepatocellular carcinoma: current status and future prospects. Front Immunol 12:4165.
   Web of Science ®Google Scholar
• Liver E. (2012). A.F.T.S.O.T., EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–43.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang W, Wang B, et al. (2016). Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma. Int J Nanomed 11:5645–69.
   PubMed Web of Science ®Google Scholar
• Mahajan S, Mahajan RK. (2012). Interactions of phenothiazine drugs with bile salts: micellization and binding studies. J Colloid Interface Sci 387:194–204.
   PubMed Web of Science ®Google Scholar
• Matloub AA, Salama AH, Aglan HA, et al. (2018). Exploiting bilosomes for delivering bioactive polysaccharide isolated from Enteromorpha intestinalis for hacking hepatocellular carcinoma. Drug Dev Ind Pharm 44:523–34.
   PubMed Web of Science ®Google Scholar
• Matsson P, Bergström CAS, Nagahara N, et al. (2005). Exploring the role of different drug transport routes in permeability screening. J Med Chem 48:604–13.
   PubMed Web of Science ®Google Scholar
• McClean S, Prosser E, Meehan E, et al. (1998). Binding and uptake of biodegradable poly-DL-lactide micro-and nanoparticles in intestinal epithelia. Eur J Pharm Sci 6:153–63.
   PubMed Web of Science ®Google Scholar
• Mohsen AM, Asfour MH, Salama AAA. (2017). Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Drug Dev Ind Pharm 43:2043–54.
   PubMed Web of Science ®Google Scholar
• Nasr MM, Reepmeyer JC, Tang Y. (1998). In vitro study of nicotine release from smokeless tobacco. J AOAC Int 81:540–3.
   PubMed Web of Science ®Google Scholar
• Natu A, Singh A, Gupta S. (2021). Hepatocellular carcinoma: understanding molecular mechanisms for defining potential clinical modalities. World J Hepatol 13:1568–83.
   PubMed Web of Science ®Google Scholar
• Niu M, Tan Y, Guan P, et al. (2014). Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study. Int J Pharm 460:119–30.
   PubMed Web of Science ®Google Scholar
• Nowacka M, Sterzynska K, Andrzejewska M, et al. (2021). Drug resistance evaluation in novel 3D in vitro model. Biomed Pharmacother 138:111536.
   PubMed Web of Science ®Google Scholar
• Pireddu R, Pibiri M, Valenti D, et al. (2018). A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine. Int J Pharm 537:257–67.
   PubMedGoogle Scholar
• Pütz G, Schmider W, Nitschke R, et al. (2005). Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytes1. J Lipid Res 46:2325–38.
   PubMed Web of Science ®Google Scholar
• Ridder DA, Weinmann A, Schindeldecker M, et al. (2022). Comprehensive clinicopathologic study of alpha fetoprotein-expression in a large cohort of patients with hepatocellular carcinoma. Int J Cancer 150:1053–66.
   PubMed Web of Science ®Google Scholar
• Rodrigues PM, Afonso MB, Simão AL, et al. (2015). Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis. Sci Rep 5:17528.
   PubMed Web of Science ®Google Scholar
• Saifi Z, Rizwanullah M, Mir SR, et al. (2020). Bilosomes nanocarriers for improved oral bioavailability of acyclovir: a complete characterization through in vitro, ex-vivo and in vivo assessment. J Drug Deliv Sci Technol 57:101634.
   Web of Science ®Google Scholar
• Sia D, Villanueva A, Friedman SL, et al. (2017). Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152:745–61.
   PubMed Web of Science ®Google Scholar
• Swarnakar NK, Thanki K, Jain S. (2014). Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Pharm Res 31:1219–38.
   PubMed Web of Science ®Google Scholar
• Tian L, Zhang S, Yi J, et al. (2022). The impact of konjac glucomannan on the physical and chemical stability of walnut oil-in-water emulsions coated by whey proteins. J Sci Food Agric 102:4003–11.
   PubMed Web of Science ®Google Scholar
• Vadia NH, Patel V, Bhalara HN. (2008). Spectrophotometric determination of cefetamet pivoxil hydrochloride and pitavastatin calcium in tablet dosage form. Indian J Pharm Sci 70:649–51.
   PubMed Web of Science ®Google Scholar
• Waglewska E, Pucek-Kaczmarek A, Bazylińska U. (2020). Novel surface-modified bilosomes as functional and biocompatible nanocarriers of hybrid compounds. Nanomaterials 10:2472.
   Web of Science ®Google Scholar
• Wang J, Tokoro T, Higa S, et al. (2006). Anti-inflammatory effect of pitavastatin on NF-κB activated by TNF-α in hepatocellular carcinoma cells. Biol Pharm Bull 29:634–9.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu Z. (2007). Effects of NK-104 on apoptosis and caspase-3 activity in hepatocellular carcinoma cells. Zhong Xi Yi Jie He Xue Bao 5:298–301.
   PubMedGoogle Scholar
• Wong RS. (2011). Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:1–14.
   PubMed Web of Science ®Google Scholar
• Wu J. (2021). The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. JPM 11:771.
   Google Scholar
• Yang L, Tucker IG, Østergaard J. (2011). Effects of bile salts on propranolol distribution into liposomes studied by capillary electrophoresis. J Pharm Biomed Anal 56:553–9.
   PubMed Web of Science ®Google Scholar
• Yao X, Hu J-F, Daniels M, et al. (2003). A novel orthotopic tumor model to study growth factors and oncogenes in hepatocarcinogenesis. Clin Cancer Res 9:2719–26.
   PubMed Web of Science ®Google Scholar
• You H-Y, Zhang W-J, Xie X-M, et al. (2016). Pitavastatin suppressed liver cancer cells in vitro and in vivo. Onco Targets Ther 9:5383–8.
   PubMed Web of Science ®Google Scholar
• Zaghloul RA, Elsherbiny NM, Kenawy HI, et al. (2017). Hepatoprotective effect of hesperidin in hepatocellular carcinoma: involvement of Wnt signaling pathways. Life Sci 185:114–25.
   PubMed Web of Science ®Google Scholar
• Zaki I, Abou-Elkhair RAI, Abu Almaaty AH, et al. (2021). Design and synthesis of newly synthesized acrylamide derivatives as potential chemotherapeutic agents against MCF-7 breast cancer cell line lodged on PEGylated bilosomal nano-vesicles for improving cytotoxic activity. Pharmaceuticals 14:1021.
   Web of Science ®Google Scholar
• Zhang X, Ng HLH, Lu A, et al. (2016). Drug delivery system targeting advanced hepatocellular carcinoma: current and future. Nanomed Nanotechnol Biol Med 12:853–69.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Pu C, Tang W, et al. (2019). Gallic acid liposomes decorated with lactoferrin: characterization, in vitro digestion and antibacterial activity. Food Chem 293:315–22.
   PubMed Web of Science ®Google Scholar